MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner.It was founded in 2013 and is based in San Francisco, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 3, 2022 | Debt Financing | $3.50M | — | — | — | Detail |
May 12, 2021 | Series A | $12M | 3 | Mountain Group Capital Rockmont Investments Scientific Health Development Partners | — | Detail |
Nov 16, 2018 | Seed | $2.92M | — | — | — | Detail |
Dec 1, 2016 | Seed | — | 3 | — | — | Detail |
Oct 13, 2015 | Seed | $1M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mountain Group Capital | Yes | Series A |
Rockmont Investments | Yes | Series A |
Scientific Health Development Partners | Yes | Series A |
MIT Alumni Angels of Northern California | — | Seed |
Primer Capital | — | Seed |
Andrew Offer | — | Seed |
MedTech Innovator | — | Grant |
Philippe Nore | — | Grant |